Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Multicenter Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

ClinicalTrials.gov ID: NCT04753164

Public ClinicalTrials.gov record NCT04753164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 1:46 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group, Proof-of-concept Study to Evaluate the Efficacy and Safety of Oral ACT-539313 in the Treatment of Adults With Moderate to Severe Binge Eating Disorder

Study identification

NCT ID
NCT04753164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Idorsia Pharmaceuticals Ltd.
Industry
Enrollment
136 participants

Conditions and interventions

Interventions

  • ACT-539313 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 55 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 15, 2021
Primary completion
Mar 20, 2022
Completion
Mar 24, 2022
Last update posted
Mar 30, 2023

2021 – 2022

United States locations

U.S. sites
30
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Southern California Research Beverly Hills California 90210
Wr-Pri, Llc Encino California 91316
Collaborative Neuroscience Network (CNS) Garden Grove California 92845
Syrentis Clinical Research Santa Ana California 92705
Connecticut Clinical Research - Cromwell Cromwell Connecticut 06416
Clinical Neurosciences Solutions Jacksonville Florida 32256
Behavioral Clinical Research North Miami Florida 33161
Clinical Neuroscience Solutions Inc Orlando Florida 31801
NeuorTrials Research Inc Atlanta Georgia 30328
Psych Atlanta P.C. Marietta Georgia 30060
Capstone Clinical Research Libertyville Illinois 60048
Collective Medical Research Prairie Village Kansas 66208
Harvard Medical School - McLean Hospital Belmont Massachusetts 02478
Boston Clinical Trials, Inc Boston Massachusetts 02131
Precise Research Centers Flowood Mississippi 39232
St. Charles Psychiatric Associates dba Midwest research group Saint Charles Missouri 63304
M3 Wake Research Las Vegas Nevada 89194
ActivMed Practices & Research, Inc. Portsmouth New Hampshire 03081
ActivMed Practices & Research Portsmouth New Hampshire 03081
Bioscience Research Mount Kisco New York 10549
Manhattan Behavioral Medicine PLLC New York New York 10036
The Medical Research Network New York New York 10128
CTI Clinical Research Center Cincinnati Ohio 45212
Patient Priority Clinical Sites Cincinnati Ohio 45221
University of Cincinnati College of Medicine - Lindner Center of HOPE Mason Ohio 45040
North Star Medical Research, LLC Middleburg Heights Ohio 44130
IPS Research Company Oklahoma City Oklahoma 73106
Oregon Center For Clinical Inv. Portland Oregon 97214
Oregon Center for Clinical Investigations, Inc. (OCCI, Inc.) Salem Oregon 97304
Clinical Trials of Texas, Inc. (CTT) San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04753164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 30, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04753164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →